BCTX
Briacell Therapeutics Corp
NASDAQ: BCTX · HEALTHCARE · BIOTECHNOLOGY
$4.18
+3.98% today
Updated 2026-04-30
Market cap
$28.13M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-14.42
Dividend yield
—
52W range
$4 – $50
Volume
0.2M
Briacell Therapeutics Corp (BCTX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | $165.00 | $43566.00 | $55934.00 | $72262.00 | $-80340.00 | $61239.00 | $565.00 | $1803.00 | $289.00 | $16877.00 | $18833.00 | $18735.00 | $19462.00 | $19417.00 | $20508.00 | $114643.00 | $147893.00 |
| Gross profit | — | — | — | $-165.00 | $-43566.00 | $-55934.00 | $-72262.00 | $80340.00 | $-61239.00 | $-565.00 | $-1803.00 | $-289.00 | $-16877.00 | $-18833.00 | $-18735.00 | $-19462.00 | $-19417.00 | $-20508.00 | $-114643.00 | $-147893.00 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | — | — | — | — | — | — | — | — | — | $137753.00 | $952150.00 | $2.12M | $3.11M | $4.94M | $2.98M | $2.58M | $10.20M | $20.60M | $37.14M | $29.50M |
| SG&A | — | — | — | $203863.00 | $323274.00 | $1.05M | $556062.00 | $423864.00 | $436166.00 | $1.33M | $942018.00 | $876162.00 | $1.05M | $932169.00 | $1.37M | $6184.00 | $7.27M | $7.94M | $8494.00 | $5.93M |
| Operating income | $-8580.00 | $-129057.00 | $-114123.00 | $-251267.00 | $-334281.00 | $-1.00M | $-559615.00 | $-290122.00 | $-476470.00 | $-1.88M | $-2.19M | $-3.21M | $-4.97M | $-6.25M | $-4.84M | $-8.90M | $-19.44M | $-31.26M | $-45.54M | $-37.73M |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $-9707.00 | $-123961.00 | $-101400.00 | $-245665.00 | $-926362.00 | $-1.02M | $-997252.00 | $-381573.00 | $-8.89M | $-3.49M | $-2.23M | $-3.22M | $-5.37M | $-5.77M | $-4.89M | $-17.51M | $-34.11M | $-27.25M | $-6.62M | $-36.63M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | $-8580.00 | $-129057.00 | $-114123.00 | $-245830.00 | $-927694.00 | $-1.03M | $-998982.00 | $-381979.00 | $-8.90M | $-3.49M | $-2.23M | $-3.22M | $-5.39M | $-5.79M | $-4.91M | $-17.53M | $-34.13M | $-27.27M | $-6.74M | $-36.78M |
| Interest expense | $0.00 | $0.00 | $0.00 | $2727.00 | $2899.00 | $13359.00 | $38009.00 | $16899.00 | $11997.00 | $7092.00 | $3627.00 | $5157.00 | $20344.00 | $31467.00 | $36204.00 | $100217.00 | $1244.00 | $0.00 | — | $51289.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-8580.00 | $-116406.00 | $-98926.00 | $-245831.00 | $-927694.00 | $-1.03M | $-998987.00 | $-381983.00 | $-8.90M | $-3.49M | $-2.23M | $-3.22M | $-5.41M | $-5.82M | $-4.94M | $-17.63M | $-34.13M | $-27.27M | $-6.55M | $-36.50M |
| Net income growth (YoY) | — | -1256.7% | +15.0% | -148.5% | -277.4% | -10.6% | +2.6% | +61.8% | -2228.7% | +60.8% | +36.1% | -44.2% | -68.1% | -7.6% | +15.0% | -256.6% | -93.6% | +20.1% | +76.0% | -457.4% |
| Profit margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |